THERALASE TECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.165 CAD | +6.45% |
|
0.00% | -5.71% |
| 04-24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
| 04-05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
Evolution of the average Target Price on Theralase Technologies Inc.
Price target over the last 5 years
History of analyst recommendation changes
1916aed879cdc16df9af43c717d7c2.nRlDqB9qlqa0DOhtADc0IBpedydr3EbFnzll0Mbp5CQ.qF4O7Sw_7v7EW9wieFR-enkZNlAF5SG9r2BT5PeAl0LOdXvOZV3jkIA72A~637ffea762ace8e89cf9d73aa535773a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.165
CAD
Average target price
0.8
CAD
Spread / Average Target
+384.85%
High Price Target
0.8
CAD
Spread / Highest target
+384.85%
Low Price Target
0.8
CAD
Spread / Lowest Target
+384.85%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- TLT Stock
- Consensus Theralase Technologies Inc.
